The Dual Role of Tumor Necrosis Factor (TNF) in Cancer Biology
With this work we intend to summarize the molecular biology of TNF (with particular regard to its tumor-related activities) and review the experimental and clinical evidence currently available describing the complex and sometime apparently conflicting relationship between this cytokine, cancer biology and antitumor therapy. We also propose a model to explain the dual effect of TNF based on the exposure time and cytokine levels reached within the tumor microenvironment. Finally, we overview recent research findings that might lead to new ways for exploiting the anticancer potential of TNF in the clinical setting.
Keywords: (DISC); (SODD); ANTI-TNF THERAPY; ANTICANCER; Cancer anorexia-cachexia syndrome; Coley's toxin; FLICE; NFkB; NFkB Pathway; NOS; NSAID; PKB/Akt; TACE; TNF; TNF Muteins; TNF PATHWAY; TNF-antagonists; TNF-converting enzyme; Tumor necrosis factor; angiogenesis; antineoplastic agents; apoptosis; biology; cancer; cancer biotherapy; carcinogenesis; cathepsin-B; ceramide; chemotherapeutic agents; haemorrhagic necrosis; isolated hepatic perfusion; isolated limb perfusion; malignant cells; murine fibrosarcoma; pro-coagulant tissue factor; proapoptotic factors; programmedcell-death; protein kinase-C; single nucleotide polymorphisms; therapy; thromosis; transcription factors
Document Type: Research Article
Publication date: 2010-10-01
- Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.